Intravenous versus Oral Etoposide : Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Abir A. Ali,Malin Grönberg,Geir Olav Hjortland,Henning Grønbæk,Morten Ladekarl,Seppo W. Langer,Staffan Welin,Lene Weber Vestermark,Pia Österlund,U. Knigge,Halfdan Sorbye,Eva Tiensuu Janson

Intravenous versus Oral Etoposide : Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

2018

Abir A. Ali
Malin Grönberg
Geir Olav Hjortland
Henning Grønbæk
Morten Ladekarl
Seppo W. Langer
Staffan Welin
Lene Weber Vestermark
Pia Österlund
U. Knigge
Halfdan Sorbye
Eva Tiensuu Janson

Intravenous versus Oral Etoposide : Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Keywords:

Biology
Diabetes mellitus
Oncology
Internal medicine
Endocrinology
Etoposide
oral etoposide
Gastroenterology
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations